VOYA Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-31,876
| Closed | -$300K | – | 2711 |
|
|
2020
Q3 | $300K | Sell |
31,876
-9,671
| -23% | -$91.9K | ﹤0.01% | 1947 |
|
|
2020
Q2 | $318K | Sell |
41,547
-4,884
| -11% | -$37.4K | ﹤0.01% | 1927 |
|
|
2020
Q1 | $287K | Hold |
46,431
| – | – | ﹤0.01% | 1938 |
|
|
2019
Q4 | $565K | Buy |
46,431
+12,877
| +38% | +$141K | ﹤0.01% | 1824 |
|
|
2019
Q3 | $388K | Sell |
33,554
-17,607
| -34% | -$185K | ﹤0.01% | 1910 |
|
|
2019
Q2 | $511K | Buy |
51,161
+13,089
| +34% | +$141K | ﹤0.01% | 1760 |
|
|
2019
Q1 | $490K | Sell |
38,072
-747
| -2% | -$11.1K | ﹤0.01% | 1792 |
|
|
2018
Q4 | $590K | Sell |
38,819
-475
| -1% | -$9.05K | ﹤0.01% | 1619 |
|
|
2018
Q3 | $786K | Hold |
39,294
| – | – | ﹤0.01% | 1557 |
|
|
2018
Q2 | $766K | Sell |
39,294
-1,272
| -3% | -$28.1K | ﹤0.01% | 1540 |
|
|
2018
Q1 | $817K | Sell |
40,566
-819
| -2% | -$13.9K | ﹤0.01% | 1497 |
|
|
2017
Q4 | $548K | Sell |
41,385
-20,252
| -33% | -$305K | ﹤0.01% | 1780 |
|
|
2017
Q3 | $1.14M | Sell |
61,637
-31,742
| -34% | -$592K | ﹤0.01% | 1332 |
|
|
2017
Q2 | $1.72M | Buy |
93,379
+78,587
| +531% | +$1.56M | ﹤0.01% | 1100 |
|
|
2017
Q1 | $334K | Hold |
14,792
| – | – | ﹤0.01% | 1983 |
|
|
2016
Q4 | $515K | Hold |
14,792
| – | – | ﹤0.01% | 1719 |
|
|
2016
Q3 | $363 | Hold |
14,792
| – | – | ﹤0.01% | 1921 |
|
|
2016
Q2 | $354K | Hold |
14,792
| – | – | ﹤0.01% | 1926 |
|
|
2016
Q1 | $346K | Hold |
14,792
| – | – | ﹤0.01% | 1923 |
|
|
2015
Q4 | $447K | Hold |
14,792
| – | – | ﹤0.01% | 1795 |
|
|
2015
Q3 | $588K | Hold |
14,792
| – | – | ﹤0.01% | 1610 |
|
|
2015
Q2 | $1.02M | Buy |
14,792
+1,635
| +12% | +$103K | ﹤0.01% | 1418 |
|
|
2015
Q1 | $719K | Hold |
13,157
| – | – | ﹤0.01% | 1664 |
|
|
2014
Q4 | $561K | Sell |
13,157
-4,783
| -27% | -$173K | ﹤0.01% | 1855 |
|
|
2014
Q3 | $572K | Hold |
17,940
| – | – | ﹤0.01% | 1809 |
|
|
2014
Q2 | $372K | Hold |
17,940
| – | – | ﹤0.01% | 2206 |
|
|
2014
Q1 | $347K | Hold |
17,940
| – | – | ﹤0.01% | 2239 |
|
|
2013
Q4 | $435K | Hold |
17,940
| – | – | ﹤0.01% | 2065 |
|
|
2013
Q3 | $385K | Hold |
17,940
| – | – | ﹤0.01% | 2105 |
|
|
2013
Q2 | $399K | Buy |
+17,940
| New | +$395K | ﹤0.01% | 2016 |
|
VOYA Investment Management's AMAG Position: Q4 2020 in Review
VOYA Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 31,876 shares — an estimated $300K sold.
VOYA Investment Management first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $1.72M in Q2 2017. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- VOYA Investment Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- VOYA Investment Management sold 31,876 AMAG Pharmaceuticals shares in Q4 2020, an estimated $300K.
- VOYA Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- VOYA Investment Management's AMAG Pharmaceuticals position peaked at $1.72M in Q2 2017.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on VOYA Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.